Latest Articles

Publication Date
All News Scientific
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Endocrine Therapy for Endometrial Cancer: Traditional Approaches and Novel Targets - Frontiers

Endocrine Therapy for Endometrial Cancer: Traditional Approaches and Novel Targets Frontiers

Published: April 15, 2025, 3:08 p.m.
Read Full Article
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer - HMP Global Learning Network

Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer HMP Global Learning Network

Published: April 11, 2025, 2:54 p.m.
Read Full Article
Miniature Horse Therapy at Stirling University - Brig Newspaper

Miniature Horse Therapy at Stirling University Brig Newspaper

Published: April 11, 2025, 8 a.m.
Read Full Article
S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer - Medscape

S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer Medscape

Published: April 10, 2025, 2:07 p.m.
Read Full Article
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma - MedPage Today

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma MedPage Today

Published: April 9, 2025, 3:15 p.m.
Read Full Article
ASCO Reading Room | Daniela Matei on Chemotherapy for Stage III Endometrial Cancer - MedPage Today

ASCO Reading Room | Daniela Matei on Chemotherapy for Stage III Endometrial Cancer MedPage Today

Published: April 9, 2025, 3:15 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!